Parkwalk invests in innovative UK growth companies across various stages of their development. Parkwalk Funds seek capital appreciation, with the added advantages to investors of the tax reliefs offered under the Enterprise Investment Scheme (EIS) and Business Investment Relief (BIR).
Each Parkwalk Fund invests in a minimum of five companies, and investee companies range from early stage through to AIM-listed, creating a diverse portfolio of sectors and business development stages, with capital raised used for development, commercialisation and expansion through to acquisition capital.
Parkwalk also manages the University of Cambridge Enterprise Fund series.
All of Parkwalk's fully-invested Funds are currently valued at a premium to original investment cost.
- Defined Investment Strategy
- Proven Track Record
- Transparency, Governance and Risk Mitigation
- EIS Investing alongside other large VC Funds
- Experienced Management Team
Parkwalk offers investors unique access to deal-flow across all stages of development. The Firm offers investor interaction with investee companies. The Firm's principals' capital markets experience helps manage investments through multiple funding stages to successful exits.